NASDAQ · MAMO

Massimo Group

$1.04 +$0.06 (+6.12%) 1D Market open

Key Metrics

$40.81M
Market cap
15.75×
P/E · TTM
$69.64M
Revenue · TTM
$2.59M
Net income
EPS · TTM $0.06
Dividend yield
Free cash flow $1.64M
Beta · 1Y 0.80
EBITDA · TTM $3.63M
Gross margin 39.9%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Apr 16
    The stock moved +20.6% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Apr 16
  • Feb 23
    From its Jan 29 high, the share price fell 74%.

    Peak close $3.34 on Jan 29; trough close $0.86 on Feb 23. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -74%
  • Feb 3
    The stock moved -59.5% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 3

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$40.81M
Enterprise value
Shares outstanding41.6M
52-wk range$0.85 – $5.59
Avg volume · 20D281.7K
Net cash
Book value / share$0.55
IndustryMiscellaneous Transportation Equipment
ExchangeNASDAQ
About Massimo Group
IPO dateApr 2, 2024
Employees100

Massimo Group is engaged in utility focused recreational, Powersports Vehicles and Boats Industry.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E15.75
P/S0.59
P/FCF24.87
EV/EBITDA
EV/Sales
Graham №$0.88

Profitability

Gross 39.9%
Operating 5.0%
Net 3.7%
FCF 2.4%
ROE / ROIC 11.7% · 14.0%

Financial Health

Current ratio1.98
Quick ratio0.54
Debt / equity
Debt / EBITDA
Net cash
Working capital$16.29M

Cash Flow · TTM

Operating CF $1.86M
Capex −$223.39K
Free cash flow $1.64M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

3 / 9
Weak fundamentals · 3 of 9 signals passing

Altman Z-Score

3.9
Safe zone (> 2.99) · bankruptcy risk negligible

Graham Number vs Price

$0.88 vs $1.04
Trades 1.2× above classic defensive value — priced for growth
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings